A New Bevacizumab Carrier for Intravitreal Administration: Focus on Stability

Bevacizumab (BVZ) is a monoclonal antibody that binds to human vascular endothelial growth factor A (VEGF-A) and inhibits the interaction between VEGF-A and VEGF receptors, thus blocking the angiogenesis. Repeated intravitreal injections of BVZ for the treatment of ocular pathologies that present an...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	Pharmaceutics
Main Authors:	Chirio, Daniela, Peira, Elena, Sapino, Simona, Chindamo, Giulia, Oliaro-Bosso, Simonetta, Adinolfi, Salvatore, Dianzani, Chiara, Baratta, Francesca, Gallarate, Marina
Format:	Artigo
Sprog:	Inglês
Udgivet:	MDPI 2021
Fag:	Article
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC8071554/ https://ncbi.nlm.nih.gov/pubmed/33921167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13040560
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

A New Bevacizumab Carrier for Intravitreal Administration: Focus on Stability

Lignende værker